DuPont Acquires Again—Targeting the Healthcare Sector!

In recent years, DuPont has continuously intensified its focus on the healthcare sector. In June 2022, DuPont officially opened its Liveo™ medical-grade silicone adhesive manufacturing facility in South Carolina, USA. In the same month, DuPont announced plans to expand its production capacity for silicone materials used in biopharmaceutical applications in China. In August 2023, DuPont completed the acquisition of Spectrum Plastics Group for $1.75 billion. Spectrum’s business partially overlapped with that of Donatelle Plastics—its core operations involve specialty medical devices and components for structural heart disease, electrophysiology, surgical robotics, and cardiovascular applications. Donatelle Plastics, with nearly 60 years of history and over 400 employees, demonstrates strong financial growth potential across multiple domains—including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neuromodulation, and orthopedics. This strategic acquisition aims to further expand DuPont’s market position in the medical device industry, signaling strong confidence from its management in the long-term growth trajectory of the healthcare equipment sector—and underscoring its high regard for the future prospects of upstream medical device markets. DuPont intends to deepen its presence through strategic transformation and expansion. By broadening its footprint in the medical device sector, DuPont is poised to enhance its competitiveness in the healthcare market and challenge the leadership positions held by current industry incumbents. ▍A Century-Old Company Reclaiming Its Glory Over the past five years, DuPont has undergone two major spin-offs and multiple rounds of business restructuring to proactively respond to global economic uncertainty and fragility. While divesting legacy businesses—including its Transportation & Materials division—it has consistently strengthened its competitive advantages and expanded its portfolio in high-potential areas such as medical materials, electronic materials, and water treatment. In Q1 2024, DuPont reported net sales of $2.9 billion and operating EBITDA (earnings before interest, taxes, depreciation, and amortization) of $682 million. Driven by sustained recovery in the electronics market and optimism toward industrial end-markets—including water treatment and medical packaging—DuPont raised its full-year financial guidance for net sales, operating EBITDA, and adjusted earnings per share, forecasting sequential improvement in both sales and profitability. In May this year, DuPont announced its formal split into three independent, publicly traded companies: New DuPont (comprising the majority of the Industrial Solutions segment—including healthcare—Water & Protection, and remaining retained businesses), Electronics, and Water. See related article: “Doubling Down on Healthcare! Global Chemical Giant DuPont Splits Again.” New DuPont will assume responsibility for the global healthcare end-market, offering products and services spanning biopharmaceutical consumables, medical devices, and medical packaging. New DuPont’s projected 2023 revenue stands at approximately $6.6 billion, with an EBITDA margin of 24%, primarily distributed across healthcare, mobility, and safety & protection—including iconic brands such as Tyvek® and Kevlar®. In healthcare, key new offerings include the latest specification of Tyvek® Tyvek® medical packaging—a high-density polyethylene fiber-based nonwoven technical material—as well as Liveo® flexible skin-conductive tapes, a silicone-based thermoset adhesive designed for electrophysiological signal sensing and transmission.

Year-on-Year Growth of 118%! Performance Soars for Chemical Giants Including BASF, Dow, and DuPont—Who’s the Most Profitable?

Recently, major global chemical companies have successively released their full-year 2021 financial results—with many reporting record-breaking performance. A B R O A D 01 BASF In 2021, BASF achieved sales of €78.6 billion (approximately $82.6 billion), up 33% from 2020. Its earnings before interest and tax (EBIT), excluding special items, reached €7.8 billion—a 118% increase year-on-year—more than double its 2020 figure and 67% higher than pre-pandemic (2019) levels. 02 Dow Inc. Dow’s full-year 2021 net sales totaled $54.968 billion (compared to $38.542 billion in 2020); operating EBIT was $9.5 billion; and net income amounted to $6.311 billion (versus $1.225 billion in 2020). Profit margins improved across all operating segments; operating cash flow reached $7.1 billion, and annual return on capital exceeded 22%. 03 DuPont DuPont’s 2021 net sales were $16.653 billion, up 16% year-on-year; net income stood at $6.467 billion (in contrast to a net loss of $2.951 billion in 2020); operating EBITDA was $4.2 billion, up 21% year-on-year; and adjusted earnings per share for the year were $4.30. 04 SABIC (Saudi Basic Industries Corporation) SABIC’s 2021 net profit surged 124% to $11 billion; free cash flow reached $10.75 billion (up from $4.91 billion in 2020); capital expenditures rose 18% to $3.19 billion—primarily driven by activities related to crude oil volume increases, the Tanajib gas plant, and development drilling programs; the company maintained a robust balance sheet, with a debt-to-equity ratio of 14.2% at year-end 2021 (down from 23.0% at year-end 2020). 05 LG Chem LG Chem’s 2021 sales totaled ₩42.6547 trillion (approximately $35.5 billion), up 41.9% year-on-year; operating profit reached ₩5.255 trillion (approximately $4.4 billion), up 178.4% year-on-year—both sales and operating profit hitting all-time highs. 06 LyondellBasell LyondellBasell’s 2021 revenue was $46.173 billion (versus $27.753 billion in 2020); net income for the year was $5.617 billion (versus $1.427 billion in 2020). 07 Linde Linde’s 2021 sales totaled $30.793 billion (versus $27.243 billion in 2020); net income for the year was $3.826 billion (versus $2.501 billion in 2020). 08 Air Liquide Air Liquide Group’s 2021 revenue was €23.335 billion (approximately $24.5 billion), up 13.9% year-on-year; operating profit was €4.16 billion, up 9.8%; and net income was €2.572 billion, up 5.6%.

DuPont tops estimates, lifts outlook as shares jump

May 13, 2026

DuPont De Nemours Inc exceeded financial estimates and raised its outlook, driving a share price jump amid strong operational results and improved market confidence.

MSN

2026-04-20

Natural Antioxidant Market Outlook 2026 | Vitafoods Europe

2026-05-05

DuPont Lifts Outlook, Plans $275 Million Buyback

2026-05-07

The Chemistry of Uncertainty

2026-05-12

Global Specialty Food Ingredients Market Projected for Explosive Growth Through 2033

2026-05-13

DuPont tops estimates, lifts outlook as shares jump